Clinical Trials

Apremilast in psoriasis: The PSOR-001 (Open-Label, Single-Arm, Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety and Preliminary Efficacy of CC-10004 in Subjects With Severe Plaque Psoriasis; NCT00604682) study

Open-label,single-arm pilot study to evaluate the pharmacodynamics, pharmacokinetics, safety, and preliminary efficacy of CC1004 in subjects with severe plaque type psoriasis (PSOR-001) (NCT00604682)

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here